CU6 ASX Chart
Snapshot
Clarity(CU6) is a leader in Targeted Copper Theranostics (TCT), developed with its proprietary SAR Technology platform. The Company has a diverse range of products in clinical trials which address both large indications (prostate cancer and breast cancer) as well as rare and orphan indications (neuroendocrine tumours (NETs) and neuroblastoma) of cancer
Share Price Activity (ASX)
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
Performance
1 Week | |
1 Month | |
2024 YTD | |
1 Year | |
vs Sector (1yr) | - |
vs ASX 200 (1yr) | +272.61% |
Key Fundamentals
Shares Issued | |
Sector | Healthcare |
Similar Companies | CUV / VRT / API |
EPS | -$0.118 |
DPS | $0.00 |
Book Value Per Share | $0.263 |
Broker Consensus
Please see the Broker Consensus page.
Latest Clarity Pharmaceuticals Ltd News
Announcements
Corporate Overview
Corporate Details
Head Office | Eveleigh NSW 2015 |
Website | www.claritypharmaceuticals.com |
Registry | Link Market Services |
Auditor | Grant Thornton Audit Pty Ltd |
Date Listed | 25 Aug 2021 |
Upcoming Calendar (Forecasted)
Date | Event |
---|---|
22/08/2024 | Report (Prelim) |
27/09/2024 | Report (Annual) |
27/02/2025 | Report (Interim) |
Former Company Names
- Clarity Pharmaceuticals Ltd has no former company names.
Sponsored Financial Content
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
CU6 directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of CU6 directors.
Shareholder Info
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.
Name | Last Notice | Total Shares | Shares Held (%) |
---|---|---|---|
TM Ventures Pty Ltd | 20/09/2023 | 18,788,460 | 7.18 |
Cabbit Pty Ltd | 20/09/2023 | 17,911,280 | 6.84 |
A.C.N. 136 437 913 Pty Ltd | 20/09/2023 | 13,266,660 | 5.07 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
No buy transactions reported by Substantial Shareholders in the past 12 months.
Shareholders Selling
12 month transaction history compiled from ASX announcements.
Date | Name | Sold | Previous % | New % |
---|---|---|---|---|
29-11-23 | Charles Waite Morgan | 13,593,040 | 5.19 | -- |
01-09-23 | Charles Waite Morgan | 5,000,000 | 7.26 | 5.19 |
01-09-23 | Matthew John Harris | 14,078,620 | 5.50 | -- |
Historical Data
Share Price History
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Historical Data
Year | Closing Price | Last Trade |
---|---|---|
2023 | $0.700 | 30 June |
2022 | $0.510 | 30 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.